MedTrace Logo

Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT

NCT03220464 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2017-07-21

No results posted yet for this study

Summary

The aim of this study is to evaluate ultra low dose chest computed tomography (ULDCT) for early diagnosis of active tuberculosis in cohort of close contacts of active pulmonary tuberculosis for 1 year follow up

Conditions

  • Tuberculosis, Pulmonary
  • Latent Tuberculosis

Interventions

RADIATION

Ultra low dose chest computed tomography (ULDCT)

Participants in the study will receive ULDCT at enrollment, after 3-month visit, and after 12-month visit.

RADIATION

Chest X-ray

Participants in the study will receive chest x-ray at enrollment, after 3-month visit, and after 12-month visit.

DIAGNOSTIC_TEST

Interferon-gamma Release Assay (IGRA)

Participants in the study will receive IGRA test at enrollment, after 3-month visit, and after 12-month visit. About 11mL of blood will be drawn from the participants for test of T-SPOT®.TB test and QuantiFERON test.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Jae-Joon Yim, MD, PhD · Seoul National University Hospital

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-20
Primary Completion
2019-04-30
Completion
2020-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03220464 on ClinicalTrials.gov